Skip to main content
SpringerLink
Log in

Austrian Experience with Etretinate

  • Chapter
Retinoid Therapy

Abstract

Etretinate has been used by our group as an experimental drug since 1976 in more than 500 patients suffering from a spectrum of hyperkeratotic skin conditions and a few disorders of the dermal collagen. Our clinical experience has been presented in several reports;1–12 it is largely in agreement with the numerous clinical studies which have been published in the past years by many, particularly European, groups. Today, the extraordinary therapeutic effects, the posology and side-effects of etretinate appear to be well known and accepted; in this paper, we therefore wish to express a few general views concerning the indications and limitations of etretinate, which have emerged from our experience with this drug.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Fritsch, P.O. (1979). Erythroderatodermia figurata variabilis Mendes da Costa: erfolgreiche Behandlung mit einem oralen aromatischen Retinoid (Ro 10–9359). Hautarzt, 30, 161

    PubMed  CAS  Google Scholar 

  2. Hönigsmann, H., Fritsch, P. and Jaschke, E. (1978). Hypertroph verhornende Variante des Morbus Darier. Erfolgreiche orale Behandlung mit einem aromatischen Retinoid (Ro 10–9359). Hautarzt, 29, 601

    PubMed  Google Scholar 

  3. Fritsch, P., Hönigsmann, H. and Jaschke, E. (1978). Epidermolytic hereditary palmo-plantar keratoderma. Report of a family and treatment with an oral aromatic retinoid. Br. J. Dermatol., 99, 561

    Article  PubMed  CAS  Google Scholar 

  4. Fritsch, P., Hönigsmann, H., Jaschke, E. and Wolff, K. (1978). Augmentation of oral Methoxsalen-photochemotherapy with an oral retinoic acid derivative. J. Invest. Dermatol., 70, 178

    Article  PubMed  CAS  Google Scholar 

  5. Fritsch, P., Hönigsmann, H., Jaschke, E. and Wolff, K. (1979). Photochemotherapy bei Psoriasis: Steigerung der Wirksamkeit durch ein orales aromatisches Retinoid. Dtsch. Med. Wochenschr., 103, 1731

    Article  Google Scholar 

  6. Elias, P.M., Fritsch, P.O., Lampe, M., Williams, M.L., Brown, B.E., Nemanic, M. and Grayson, S. (1981). Retinoid effects on epidermal structure differentiation and permeability. Lab. Invest., 44, 531

    PubMed  CAS  Google Scholar 

  7. Fritsch, P.O., Pohlin, G., Längle, U. and Elias, P.M. (1981). Response of epidermal cell proliferation to orally administered aromatic retinoid. J. Invest. Dermatol, 11, 287

    Article  Google Scholar 

  8. Fritsch, P. (1981). Oral retinoids in dermatology. Dermatology, 20, 314

    Article  CAS  Google Scholar 

  9. Wolff, K. and Fritsch, P.O. (1982). Retinoid — PUVA photochemotherapy. In Färber, E.M., Cox, A.J., Nall, L. and Jacobs, P.H. (eds.). Psoriasis, pp. 211–219. (New York: Grune & Stratton)

    Google Scholar 

  10. Nemanic, M.K., Fritsch, P.O. and Elias, P.M. (1983). Perturbations of membrane glycosylation in retinoid-treated epidermis. J. Am. Acad. Dermatol, 6, 801

    Article  Google Scholar 

  11. Pichler, E. and Fritsch, P. (1983). Xeroderma pigmentosum: Tumorprophylaxe mit Etretinat. Hautarzt. (In press)

    Google Scholar 

  12. Fritsch, P., Klein, G., Auböck, J. and Hintner, J. (1982). Letter to the Editor, J. Am. Acad. Dermatol, submitted

    Google Scholar 

  13. Ott, F. (1977). Behandlung der Psoriasis mit einem oral wirksamen aromatischen Retinoid. Schweiz. Med. Wochenschr., 107, 144

    PubMed  CAS  Google Scholar 

  14. Orfanos, C.E. and Goerz, G. (1978). Orale Psoriasis-Therapie mit einem neuen aromatischen Retinoid (Ro 10–9359). Dtsch. Med. Wochenschr., 103, 195

    Article  PubMed  CAS  Google Scholar 

  15. Stollenwerk, R., Rischer-Hoinkes, H., Komenda, K. and Schilling, F. (1981). Clinical observations on oral retinoid therapy of psoriatic arthropathy (Ro 10–9359). In Orfanos, C.E., Braun-Falco, O., Farber, E.M., Grupper, Ch., Polano, M.K. and Schuppli, R. (eds.). Retinoids: Advances in Basic Research and Therapy, pp. 205–209. (Berlin, Heidelberg, New York: Springer-Verlag)

    Google Scholar 

  16. Rosenthal, M. (1979). Retinoid in der Behandlung von Psoriasis-Arthritis. Schweiz. Med. Wochenschr., 109, 1912

    PubMed  CAS  Google Scholar 

  17. Fritsch, P., Rauschmeier, W. and Neuhofer, J. (1983). Response of psoriatic arthropathy to arotinoid (Ro 13–6298): a pilot study. (In press)

    Google Scholar 

  18. Milstone, L.M., McGuire, J. and Ablow, R.C. (1982). Premature epiphyseal closure in a child receiving oral 13-cis-retinoic acid. J. Am. Acad. Dermatol, 7, 663

    Article  PubMed  CAS  Google Scholar 

  19. Bollag, W. (1975). Prophylaxis of chemically induced epithelial tumors with an aromatic retinoid acid analogue (Ro 10–9359). Eur. J. Cancer., 11, 721

    Article  PubMed  CAS  Google Scholar 

  20. Sporn, M.B. and Newton, D.L. (1979). Chemoprevention of cancer with retinoids. Fed. Froc, 38, 2538

    Google Scholar 

  21. Haydey, R.P., Reed, M.L., Dzubow, L.M. and Shupack, J.L. (1980). Treatment of keratoacanthomas with oral 13-cis-retinoic acid. N. Engl. J. Med., 303, 506

    Article  Google Scholar 

  22. Peck, G.L., Gross, E.G., Butkus, D. and DiGiovanna, J. (1982). Chemoprevention of basal cell carcinoma with isotretinoin. J. Am. Acad. Dermatol., 6, 815

    Article  PubMed  CAS  Google Scholar 

  23. Braun-Falco, O., Galosi, A., Dorn, M. and Plewig, G. (1982). Tumorprophylaxe bei Xeroderma pigmentosum mit aromatischem Retinoid (Ro 10–9359). Hautarzt, 33, 445

    PubMed  CAS  Google Scholar 

  24. Schnitzler, L. and Verret, J.L. (1981). Retinoid and skin cancer prevention. In Orfanos, C.E., Braun-Falco, O., Farber, E.M., Grupper, Ch., Polano, M.K. and Schuppli, R. (eds.). Retinoids: Advances in Basic Research and Therapy, pp. 385–388. (Berlin, Heidelberg, New York: Springer-Verlag)

    Google Scholar 

  25. Brinckerhoff, C.E., McMillan, R.M Dayer, J.-M. and Harris, E.D. (1980). Inhibition by retinoic acid of collagenase proc action in rheumatoid synovial cells. N. Engl. J. Med., 303, 432

    Article  PubMed  CAS  Google Scholar 

  26. Bauer, E.A., Seltzer, J.L. and Eisen, A: (1982). Inhibition of collagen degradative enzyme by retinoic acid in vitro. J. Am. Aad. Dermatol., 6, 603

    Article  CAS  Google Scholar 

  27. Nelson, D.L. and Balian, G. (1983). The nfluence of retinoic acid on collagen synthesis by skin fibroblasts. J. Invest. Dermatol, 80, 357 (A)

    Article  Google Scholar 

  28. Hein, R., Krieg, T., Müller, P.K. and Braun-Falco, O. (1983). Einfluβ von retinoiden auf die Regulation der Kollagensynthese mesenchymaler Zellen. Arch. Derm. Res. (In press)

    Google Scholar 

  29. Lacroix, A., Anderson, G.D.L. and Lippman, M.E. (1980). Retinoids and cultured human fibroblasts. Effects on cell growth and presence of cellular retinoic acid-binding protein. Exp. Cell Res., 130, 339

    Article  PubMed  CAS  Google Scholar 

  30. Jetten, A.M., Jetten, M.E.R., Shapiro, S.S. and Poon, J.P. (1979). Characterization of the action of retinoids on mouse fibroblast cell lines. Exp. Cell Res., 119, 289

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. P. Fritsch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

W. J. Cunliffe A. J. Miller

Rights and permissions

Reprints and permissions

Copyright information

© 1984 MTP Press Limited

About this chapter

Cite this chapter

Fritsch, P. (1984). Austrian Experience with Etretinate. In: Cunliffe, W.J., Miller, A.J. (eds) Retinoid Therapy. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6349-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-6349-1_5

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-011-6351-4

  • Online ISBN: 978-94-011-6349-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation